News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Parsons James T.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 16,968 options to buy
@ $2.73, valued at
$46.3k
|
|
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2022 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 16,773 shares
@ $3.58, valued at
$60k
|
|
11/19/2021 |
4
| Parsons James T. (CFO) has filed a Form 4 on Trillium Therapeutics Inc.
Txns:
| Disposed/sold 180,000 options to buy
@ $12.03, valued at
$2.2M
Disposed/sold 94,792 options to buy
@ $0 Disposed/sold 59,896 options to buy
@ $0 Disposed/sold 5,761 options to buy
@ $0 Disposed/sold 36,204 options to buy
@ $0 Disposed/sold 24,390 options to buy
@ $0 Disposed/sold 30,171 options to buy
@ $0 |
|
07/16/2021 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 9,393 options to buy
@ $3.64, valued at
$34.2k
|
|
01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2020 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Granted 8,102 shares
@ $4.59, valued at
$37.2k
Granted 13,306 options to buy
@ $4.64, valued at
$61.7k
|
|
06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/11/2018 |
4
| Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns:
| Bought 2,250 shares
@ $4, valued at
$9k
|
|
|
|